1
Alegria Larry Andrew, Chong Wesley Kwan Mung, Chu Shaosong, Duvadie Rohit Kumar, Li Lin, Romines William Henry Iii, Yang Yi, Bleckman Ted Michael: N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors. Pfizer, Alegria Larry Andrew, Chong Wesley Kwan Mung, Chu Shaosong, Duvadie Rohit Kumar, Li Lin, Romines William Henry Iii, Yang Yi, Bleckman Ted Michael, LUMB J Trevor, September 2, 2004: WO/2004/074283 (28 worldwide citation)

Aminothiazole compounds with N-containing cycloalkyl at the 2-amino position which are represented by the Formula (I), or a pharmaceutically acceptable prodrug of said compound, or pharmaceutically acceptable salt of said compound, modulate and/or inhibit the cell proliferation and activity of prote ...


2
Chu Shao Song, Alegria Larry Andrew, Bender Steven Lee, Benedict Suzanne Pritchett, Borchardt Allen J, Kania Robert Steven, Nambu Mitchell David, Tempczyk Russell Anna Maria, Sarshar Sepehr, Bhumralkar Dilip, Peng Zhengwei, Yang Yi Michelle: Diaminothiazoles and their use for inhibiting protein kinases. Agouron Pharmaceuticals, PINO Mark J, December 14, 2000: WO/2000/075120 (4 worldwide citation)

Diaminothiazole compounds of formula (I) that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction in order to modulate and/or inhibit unwanted cell ...


3
Chu Shao Song, Alegria Larry Andrew, Bleckman Ted Michael, Chong Wesley K M, Duvadie Rohit K, Li Lin, Reich Siegfried H, Romines William H, Wallace Michael B, Yang Yi: Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use. Agouron Pharmaceuticals, Chu Shao Song, Alegria Larry Andrew, Bleckman Ted Michael, Chong Wesley K M, Duvadie Rohit K, Li Lin, Reich Siegfried H, Romines William H, Wallace Michael B, Yang Yi, HSU Wendy Lei, January 16, 2003: WO/2003/004467 (1 worldwide citation)

Aminothiazole compounds with mono-/di-substituted benzamide are represented by the Formula (I), and their pharmaceutically acceptable salts, pharmaceutically acceptable prodrugs, pharmaceutically active metabolites, and pharmaceutically acceptable salts of said metabolites are described. These agent ...


4
Chu Shao Song, Alegria Larry Andrew, Bleckman Ted Michael, Chong Wesley K M, Duvadie Rohit K, Li Lin, Reich Siegfried H, Romines William H, Wallace Michael B, Yang Yi: Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use. Agouron Pharma, July 21, 2004: EP1438046-A2

Aminothiazole compounds with mono-/di-substituted benzamide are represented by the Formula (I), and their pharmaceutically acceptable salts, pharmaceutically acceptable prodrugs, pharmaceutically active metabolites, and pharmaceutically acceptable salts of said metabolites are described. These agent ...


5
Alegria Larry Andrew, Dress Klaus Ruprecht, Huang Buwen, Kumpf Robert Arnold, Lewis Kathleen Kingsley, Matthews Jean Joo, Sakata Sylvie Kim, Canan Koch Stacie Sara, Virgil Christopher Scott: Hiv protease inhibitors, compositions containing the same and their pharmaceutical uses. Pfizer, Alegria Larry Andrew, Dress Klaus Ruprecht, Huang Buwen, Kumpf Robert Arnold, Lewis Kathleen Kingsley, Matthews Jean Joo, Sakata Sylvie Kim, Canan Koch Stacie Sara, Virgil Christopher Scott, FULLER Grover F Jr, March 24, 2005: WO/2005/026114

This invention relates to a novel series of chemical compounds useful as Human immunodeficiency Virus (HIV) protease inhibitors and to the use of such compounds as antiviral agents. The invention further relates to pharmaceutical compositions containing such antiviral agents, and their uses and mate ...


6
Chu Shao Song, Alegria Larry Andrew, Bender Steven Lee, Benedict Suzanne Pritchett, Borchardt Allen J, Kania Robert Steven, Nambu Mitchell David, Tempczyk Russell Anna Maria, Sarshar Sepehr, Bhumralkar Dilip, Zhengwei Peng, Yang Yi Michelle: Diaminothiazoles and their use for inhibiting protein kinases. Agouron Pharma, February 27, 2002: EP1181283-A1

Diaminothiazole compounds of formula (I) that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction in order to modulate and/or inhibit unwanted cell ...


7
Chu Shao Song, Alegria Larry Andrew, Bender Steven Lee, Benedict Suzanne Pritchett, Borchardt Allen J, Kania Robert Steven, Nambu Michell David, Sarshar Sepehr, Tempczyk Russell Anna Maria, Bhumralkar Dilip, Zhengwei Peng, Yang Yi Michelle: Diaminothiazoles and their use for inhibiting protein kinases. Agouron Pharmaceuticals, February 27, 2002: KR1020017015384

Diaminothiazole compounds of formula (I) that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction in order to modulate and/or inhibit unwanted cell ...